Table 3.
Serum total cholesterol concentrations in respondents treated with lipid-lowering drugs, corrected for within-person variability.
Serum total cholesterol | Primary prevention (n = 294) | Secondary prevention (n = 136) | Total (n = 430) |
---|---|---|---|
≤ 5.00 mmol l−1 | 36 (12.2%) | 47 (34.6%) | 83 (19.3%) |
5.01–6.50 mmol l−1 | 164 (55.8%) | 69 (50.7%) | 233 (54.2%) |
6.51–8.00 mmol l−1 | 84 (28.6%) | 15 (11.0%) | 99 (23.0%) |
> 8.00 mmol l−1 | 10 (3.4%) | 5 (3.7%) | 15 (3.5%) |